Wall Street analysts expect Proto Labs, Inc. (NYSE:PRLB) to report $85.53 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Proto Labs’ earnings, with the lowest sales estimate coming in at $85.30 million and the highest estimate coming in at $85.99 million. Proto Labs posted sales of $78.17 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 9.4%. The company is scheduled to announce its next quarterly earnings report on Thursday, October 26th.
According to Zacks, analysts expect that Proto Labs will report full-year sales of $85.53 million for the current year, with estimates ranging from $333.89 million to $336.70 million. For the next financial year, analysts anticipate that the company will post sales of $369.60 million per share, with estimates ranging from $366.39 million to $374.31 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that cover Proto Labs.
Proto Labs (NYSE:PRLB) last posted its quarterly earnings results on Thursday, July 27th. The industrial products company reported $0.49 EPS for the quarter, beating the Zacks’ consensus estimate of $0.43 by $0.06. Proto Labs had a return on equity of 11.75% and a net margin of 14.59%. The business had revenue of $82.04 million during the quarter, compared to the consensus estimate of $80.49 million. Proto Labs’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.45 earnings per share.
A number of analysts have commented on the company. Piper Jaffray Companies reaffirmed a “hold” rating and set a $67.00 target price on shares of Proto Labs in a report on Friday, July 28th. Zacks Investment Research cut shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, June 28th. Finally, Dougherty & Co raised shares of Proto Labs from a “sell” rating to a “neutral” rating in a report on Tuesday, June 27th. Four analysts have rated the stock with a hold rating, Proto Labs has an average rating of “Hold” and an average target price of $59.33.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/10/03/proto-labs-inc-prlb-expected-to-post-quarterly-sales-of-85-53-million.html.
Proto Labs (NYSE:PRLB) opened at 81.55 on Tuesday. The firm’s 50-day moving average price is $73.35 and its 200 day moving average price is $65.22. Proto Labs has a one year low of $43.10 and a one year high of $81.60. The firm has a market capitalization of $2.17 billion, a P/E ratio of 47.41 and a beta of 0.99.
In related news, VP Robert Bodor sold 741 shares of the company’s stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $73.84, for a total transaction of $54,715.44. Following the completion of the sale, the vice president now owns 17,319 shares of the company’s stock, valued at approximately $1,278,834.96. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 7.78% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. increased its position in shares of Proto Labs by 146,773.4% during the 1st quarter. BlackRock Inc. now owns 2,905,155 shares of the industrial products company’s stock worth $148,453,000 after purchasing an additional 2,903,177 shares during the last quarter. Vanguard Group Inc. lifted its position in Proto Labs by 2.7% in the second quarter. Vanguard Group Inc. now owns 2,176,051 shares of the industrial products company’s stock valued at $146,339,000 after buying an additional 56,724 shares during the last quarter. Janus Henderson Group PLC lifted its position in Proto Labs by 411.4% in the second quarter. Janus Henderson Group PLC now owns 1,301,429 shares of the industrial products company’s stock valued at $87,521,000 after buying an additional 1,046,960 shares during the last quarter. New York State Common Retirement Fund lifted its position in Proto Labs by 0.8% in the second quarter. New York State Common Retirement Fund now owns 638,269 shares of the industrial products company’s stock valued at $42,924,000 after buying an additional 4,934 shares during the last quarter. Finally, State Street Corp lifted its position in Proto Labs by 5.2% in the second quarter. State Street Corp now owns 595,748 shares of the industrial products company’s stock valued at $40,063,000 after buying an additional 29,561 shares during the last quarter.
Proto Labs Company Profile
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.